Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edratide (TV-4710) in systemic lupus erythematosus
2005-001391-12Phase 2Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Jun 2005
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of edratide in systemic lupus erythematosus (SLE) (4 arms), sponsored by Teva Pharmaceutical Industries Ltd. Primary endpoint: Adjusted mean SLEDAI-2K over time. Started Jun 2005; status: completed.
02
Drugs
edratide
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on 2005-001391-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001391-12.